Total Debt for Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's latest reported total debt is $6.95B USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
BIIB
Currently viewingTotal DebtSwitch metric
Latest period
$6.95B
YoY change
+4.8%
5Y CAGR
-2.4%
Peak year (2020)
$7.83B
Latest annual
$6.95B
Total Debt history chart for Biogen (BIIB) from 1985 to 2025
Total Debt history table for Biogen (BIIB) from 1985 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $6.95B | +4.8% | ||
| 2024 | $6.63B | -9.6% | ||
| 2023 | $7.34B | +10.9% | ||
| 2022 | $6.61B | -13.0% | ||
| 2021 | $7.60B | -2.9% | ||
| 2020 | $7.83B | +22.9% | ||
| 2019 | $6.37B | +7.3% | ||
| 2018 | $5.94B | -0.0% | ||
| 2017 | $5.94B | -8.9% | ||
| 2016 | $6.52B | -0.1% | ||
| 2015 | $6.53B | +1015.2% | ||
| 2014 | $585.20M | -1.8% | ||
| 2013 | $595.93M | -47.8% | ||
| 2012 | $1.14B | +7.2% | ||
| 2011 | $1.06B | -11.6% | ||
| 2010 | $1.20B | +9.4% | ||
| 2009 | $1.10B | -1.2% | ||
| 2008 | $1.11B | -28.8% | ||
| 2007 | $1.56B | +1516.4% | ||
| 2006 | $96.69M | +122.6% | ||
| 2005 | $43.44M | -94.9% | ||
| 2004 | $850.31M | -4.2% | ||
| 2003 | $887.27M | +1997.7% | ||
| 2002 | $42.30M | -48.5% | ||
| 2001 | $82.16M | -24.8% | ||
| 2000 | $109.32M | -3.3% | ||
| 1999 | $113.06M | +40.8% | ||
| 1998 | $80.33M | -12.3% | ||
| 1997 | $91.55M | +38.1% | ||
| 1996 | $66.27M | +92.1% | ||
| 1995 | $34.49M | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — | ||
| 1989 | $0 | -100.0% | ||
| 1988 | $4.80M | -7.7% | ||
| 1987 | $5.20M | +18.2% | ||
| 1986 | $4.40M | +22.2% | ||
| 1985 | $3.60M | — |
Total Debt values are taken from Biogen's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Biogen (BIIB) most recent annual total debt stands at $6.95B (2025) – edged up 4.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Biogen total debt compounded at -2.4% per year, with a net decline across the window.
The highest annual total debt of $7.83B was reported in 2020. The lowest in the available history was $0 in 1989.
Among 8 Healthcare peers, Biogen (BIIB) ranks 9th; the peer median for total debt is $52.57B.
Biogen Total Debt by Year
Biogen Total Debt 2025: $6.95B
Biogen total debt in 2025 was $6.95B, edged up 4.8% from 2024.
Biogen Total Debt 2024: $6.63B
Biogen total debt in 2024 was $6.63B, declined 9.6% below 2023.
Biogen Total Debt 2023: $7.34B
Biogen total debt in 2023 was $7.34B, grew 10.9% from 2022.
Biogen Total Debt 2022: $6.61B
Biogen total debt in 2022 was $6.61B, declined 13.0% below 2021.
Biogen Total Debt 2021: $7.60B
Biogen total debt in 2021 was $7.60B.
See more financial history for Biogen (BIIB).
Sector peers — Total Debt
Companies in the same sector as Biogen, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is Biogen's total debt?
- Latest reported total debt for Biogen (BIIB) is $6.95B (period ending December 31, 2025).
How has Biogen total debt changed year-over-year?
- Biogen (BIIB) total debt changed +4.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Biogen total debt?
- Biogen (BIIB) total debt compound annual growth rate is -2.4% over the most recent 5 years available.
When did Biogen total debt hit its highest annual value?
- Biogen total debt reached its highest annual value of $7.83B in 2020.
What was Biogen total debt in 2024?
- Biogen (BIIB) total debt in 2024 was $6.63B.
What was Biogen total debt in 2025?
- Biogen (BIIB) total debt in 2025 was $6.95B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BIIB Overview
Company profile, financial tools, and key metrics
BIIB Revenue Counter
Earns $311.09 every second. See per minute, hour, and day.
BIIB Earnings Counter
Earns $41.01 per second net profit. See per minute, hour, and day.
BIIB Economic Scale
Exceeds Bermuda's GDP. Compare with world economies.
BIIB What If Invested
What if you had invested $1,000? See historical returns from any date.
BIIB How It Makes Money
Discover visual breakdown of $9.81B in revenue — where it comes from and where it goes.
BIIB Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BIIB Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BIIB Daily Price Character
Explosive · 48.1% historical win rate (green days). Streaks & record days.
BIIB Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BIIB Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.